Press

Reunion Neuroscience Inc. Commenced Trading on the Toronto Stock Exchange August 17, 2022

Aug 18 • 2 min read

Reunion Neuroscience Inc., a global leader in the discovery and development of innovative of psychedelic-inspired therapeutics for improved mental health outcomes, is pleased to announce that its common shares will commence trading on the Toronto Stock Exchange under the ticker symbol “REUN” at the opening of the market on August 17, 2022. Trading of the…

PharmAla Biotech First Publicly Traded Company to Produce GMP MDMA

Aug 18 • 3 min read

PharmAla Biotech (CSE: MDMA) has achieved a historic milestone: it is currently the only publicly-traded company to have produced GMP MDMA at scale. The company believes that it is currently the only source for commercially-available GMP MDMA other than the Multidisciplinary Association for Psychedelic Studies (MAPS). With the release of this large-scale batch of LaNeo™ MDMA…

Core One Labs: Vocan Successfully Converts Psilocin Precursor into Psilocybin

Aug 17 • 2 min read

Further to its press release dated August 12, 2022, Core One Labs Inc. (CSE: COOL | OTCQB: CLABF | Frankfurt: LD6 | WKN: A3CSSU) is pleased to announce that its wholly-owned subsidiary Vocan Biotechnologies Inc. has successfully employed enzymatic production methods to convert a chemically produced psilocin developed by the Company’s recently acquired Awakened Biosciences Inc.’s, into…

Delic Announces Two Key Executive Appointments

Aug 17 • 4 min read

Delic Holdings Corp (CSE: DELC | OTCQB: DELCF | FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared details regarding two executive appointments. Matt Stang, co-founder and CEO of Delic, has been appointed to the role of Executive Chairman. Kevin Nicholson, COO of Delic, will transition into the role of Chief…

Filament Health Announces Eighth Patent Issuance

Aug 17 • 2 min read

Filament Health Corp. (OTCQB: FLHLF | NEO: FH | FSE: 7QS), a clinical-stage natural psychedelic drug development company, today announced that it has been issued an eighth patent for the extraction and standardization of natural psilocybin and associated psychedelic compounds. Filament’s latest patent was issued by the Canadian Intellectual Property Office (CIPO) and describes technology for…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435